Desert King

About Desert King

40 years ago, we set out to find scientific solutions using natural components. Since then, Desert King® has led in responsibly sourcing and reliably delivering saponin-based products worldwide, including our QS-21, recognized as the benchmark for human vaccine adjuvants. As the proven supplier of Quillaja saponins used in five globally approved vaccines, including COVID-19, malaria, RSV, and shin...

Certifications
  • Country/Region:
    Chile
  • On CPHI since:
    2024
  • Certificates:
    3
  • Employees:
    250 - 499
Company types
Manufacturer/Innovator
Primary activities
Animal Health
Excipients Manufacturer
Natural Extracts
Pharmaceutical Company (innovator finished products)
Contact info

Products from Desert King (3)

  • QS-21 (Saponin-Based Vaccine Adjuvant)

    Product QS-21 (Saponin-Based Vaccine Adjuvant)

    - Desert King QS-21 is the globally accepted human vaccine-quality benchmark. - QS-21 is one of the world’s most powerful immunostimulants. - QS-21 is derived from the bark of the Quillaja saponaria Molina tree using advanced HPLC separation technology for purification. - QS-21 is a particular saponin ...
  • VetSap® (Purified Quillaja Bark Saponin, use in Veterinary Vaccines and Preclinical Research)

    Product VetSap® (Purified Quillaja Bark Saponin, use in Veterinary Vaccines and Preclinical Research)

    VetSap® is a veterinary vaccine adjuvant derived from a semi-purified saponin fraction of the Quillaja saponaria tree bark. It is formulated with the purest saponin adjuvant on the market, boasting 90% saponin purity. Customers can expect consistent saponin purity and profile in every batch, with VetSap® s...
  • QS-21

    Product QS-21

    - Desert King QS-21 is the globally accepted human vaccine-quality benchmark.
    - QS-21 is one of the world’s most powerful immunostimulants. 


    - QS-21 is derived from the bark of the Quillaja saponaria Molina tree using advanced HPLC separation technology for purification. 

    qq...